RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Nov 2010 - 5 pages - $500
Acute Coronary Syndromes Therapy Area Pipeline Report
Nov 2010 - 329 pages - $1,495
Epidemiology: Acute Coronary Syndrome - Now affecting primarily the oldest populations
Jul 2011 - 46 pages - $3,800
Acute Coronary Syndromes - Pipeline Review, Q1 2011
Feb 2011 - 62 pages - $500
Cardiac Markers
Jul 2006 - 140 pages - $2,500
The Future of Cardiovascular Diagnostics: Impact of technological advances on growth opportunities and future market outlook
Mar 2010 - 180 pages - $3,835
Diagnostics Partnering Terms and Agreements
Feb 2012 - 1350 pages - $2,695
Innovations in Cardiovascular Disease Management
May 2007 - 183 pages - $2,875
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
Apr 2008 - 265 pages - $3,835
Acute Coronary Syndrome - Pipeline Review, H2 2011
Sep 2011 - 106 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Genetic diagnostics del
Therapeutic target
Cardiovascular del
Acute coronary syndromes del
Angina, unstable del
Year
1999 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us